NPPA Slaps Rs 79.97 Lakh Notice on AstraZeneca for Alleged Betaloc-50 Overcharging Written By Parthika Patel30 July 2026 10:18 PM ISTNPPA has alleged that AstraZeneca Pharma India sold or marketed Betaloc-50 (Metoprolol 50 mg tablets) at a maximum retail price (MRP) higher than the...
CDSCO Approves AstraZeneca's Enhertu for Neoadjuvant HER2-Positive Breast Cancer Written By Parthika Patel28 July 2026 10:16 PM ISTNew Delhi: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation (CDSCO), Directorate General...
AstraZeneca's Ultomiris Fails Late-Stage Trial in Stem Cell Transplant Blood Vessel Disorder Written By sheeba farhat28 July 2026 6:11 PM ISTBengaluru: AstraZeneca said on Monday its rare disease drug Ultomiris failed a late-stage trial in patients with a blood vessel complication following...
Alembic, NATCO Receive USFDA Tentative Approval for Generic Cancer Drug Olaparib Written By sheeba farhat20 July 2026 8:33 PM ISTMumbai: Alembic Pharmaceuticals Limited (Alembic) has announced that its Partner NATCO Pharma Limited (NATCO) has received tentative approval from the...
CDSCO Approves AstraZeneca's Fasenra for Hypereosinophilic Syndrome in India Written By Parthika Patel18 July 2026 5:05 PM ISTBengaluru: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organization (CDSCO), Directorate General...
USFDA Approves Celcuity's First Cancer Drug Revtorpyk for Advanced Breast Cancer Written By sheeba farhat15 July 2026 9:45 PM ISTBengaluru: The U.S. FDA has approved Celcuity's drug for an advanced form of breast cancer, the regulator said on Tuesday, making it the company's...
AstraZeneca's Wainua Fails Late-Stage Heart Disease Trial, Analysts Flag Study Design Concerns Written By sheeba farhat10 July 2026 11:15 AM ISTLondon: AstraZeneca's nerve disease drug Wainua, made in partnership with Ionis, unexpectedly failed a pivotal heart-disease trial, hitting the firm's...
AstraZeneca Signs USD 2.1 Billion COPD Drug Licensing Deal with Sino Biopharm Unit Written By sheeba farhat9 July 2026 11:37 PM ISTShanghai: AstraZeneca will pay a subsidiary of Sino Biopharmaceutical USD 200 million upfront for the rights outside of China to an experimental...
AstraZeneca Signs USD 1.77 Billion Pact with CSPC to Develop Kidney Disease Therapies Written By sheeba farhat3 July 2026 11:26 PM ISTShanghai: AstraZeneca has entered into a deal worth up to USD 1.77 billion with CSPC Pharmaceutical Group to discover and develop experimental...
FDA Advisory Panel Backs Moderna's mRNA Flu Vaccine for Adults Aged 50 and Older Written By sheeba farhat21 Jun 2026 10:15 AM ISTBengaluru: Advisers to the U.S. Food and Drug Administration on Thursday backed approval of Moderna's flu vaccine for adults aged 50 and older, saying...
Pfizer Reviews Germany Investments Amid Concerns Over Drug Pricing Reforms Written By sheeba farhat12 Jun 2026 10:19 PM ISTLondon: Pfizer is reviewing ​the timing and scope of planned investments in Germany, CEO Albert Bourla ​said in a letter to Chancellor Friedrich Merz,...
AstraZeneca Gets EMA Panel Nod for Camizestrant Breast Cancer Pill After USFDA Setback Written By sheeba farhat24 May 2026 10:30 AM ISTLondon: A European Medicines Agency committee on Friday backed approval for AstraZeneca's experimental breast cancer pill, camizestrant, differing...
